Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -10,560 | -9,020 | -2,846 | -831 |
| Other Working Capital | -83 | -193 | 56 | 20 |
| Other Operating Activity | 9,047 | 8,067 | 2,462 | 49 |
| Operating Cash Flow | $-1,597 | $-1,147 | $-329 | $-762 |
| Cash Flows From Investing Activities | ||||
| Other Investing Activity | 0 | 0 | 0 | -100 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-100 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 900 | 900 | 900 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 2,056 |
| Financing Cash Flow | $900 | $900 | $900 | $2,056 |
| Exchange Rate Effect | -23 | -16 | 14 | 35 |
| Beginning Cash Position | 1,371 | 1,371 | 1,371 | 142 |
| End Cash Position | 651 | 1,108 | 1,956 | 1,371 |
| Net Cash Flow | $-720 | $-262 | $586 | $1,229 |
| Free Cash Flow | ||||
| Operating Cash Flow | -1,597 | -1,147 | -329 | -762 |
| Free Cash Flow | -1,597 | -1,147 | -329 | -762 |